Hyperlipidemias: all 839 studies

Page 5 of 9. Open to participants first (107), then studies with results posted, then the rest; newest registration first within each.

• Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking StatinsCompletedNCT03961763Not applicable
• Postprandial Monocyte Maturation and Vascular Dysfunction Following High-Fat Meals - Study 1CompletedNCT03958734Not applicable
• Effect of Consumption of Bagel Without Palm Oil on Postprandial LipidemiaCompletedNCT03950752Not applicable
• Ezetimibe-Rosuvastatin Evaluation StudyStatus unknownNCT03947866
• The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With HyperlipidemiaCompletedNCT03944109Phase 1/2
• Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk ReductionCompletedNCT03895580Not applicable
• Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia.Status unknownNCT03884127
• Hospital-level Variation in the Management of Blood Pressure and Low-density Lipoprotein in the Outpatient Hypertensives in China-a Cross Sectional StudyStatus unknownNCT03862183
• Effects of Oral Glucose and Teduglutide on Plasma LipoproteinsStatus unknownNCT03860688Phase 2/3
• Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination TabletsCompletedNCT03847506Phase 4
• Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride LevelCompletedNCT03828188Not applicable
• Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial DysbetalipoproteinemiaStatus unknownNCT03811223Phase 4
• Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337CompletedNCT03793985Phase 1
• Viscosity of Fibre Predicts Cholesterol-lowering in Healthy IndividualsCompletedNCT03741621Phase 2
• Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCICompletedNCT03718286Phase 2
• The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic PatientsCompletedNCT03708887Not applicable
• The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.CompletedNCT03690778Phase 1
• the Related Factors of Bariatric Surgery on LipidemiaStatus unknownNCT03689803Not applicable
• Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic SubjectsCompletedNCT03680027Not applicable
• Bioequivalence Study of CJ-30061 in Healthy Male VolunteersCompletedNCT03657472Phase 1
• Designing Biofunctional Dairy Foods: Matrix Structure of Dairy Products in Relation to LipaemiaCompletedNCT03656367Not applicable
• Golden Black Seed: Support of Metabolic Health and General Wellness.CompletedNCT03643094Not applicable
• Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With HyperlipidemiaStatus unknownNCT03639480Phase 3
• Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072CompletedNCT03632668Phase 1
• Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy StudyStatus unknownNCT03607383Phase 2
• Virtual Visits at Brigham and Women's HospitalTerminatedNCT03592355Not applicable
• Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012CompletedNCT03586037Phase 1
• Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With HyperlipidemiaCompletedNCT03566316Phase 3
• Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial LipemiaTerminatedNCT03559309Phase 4
• Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate HyperlipidemiaCompletedNCT03550287Phase 4
• Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With HyperlipidemiaCompletedNCT03536598Phase 3
• L-NMMA on GLP-2 Mediated Intestinal Lipoprotein ReleaseCompletedNCT03534661Phase 2/3
• Obesity-related Health Benefits of ApplesCompletedNCT03523403Not applicable
• Emulsion Droplet Physical State on Postprandial Lipemia and SatietyCompletedNCT03515590Not applicable
• Effects of Nicotinamide Riboside on Metabolism and Vascular FunctionCompletedNCT03501433Not applicable
• The Effect of n-3 PUFA Plant Oil Intake on Human MetabolismStatus unknownNCT03484988Not applicable
• Glucose-stimulated Gut Lipid ReleaseCompletedNCT03464240Not applicable
• Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult VolunteersCompletedNCT03461081Phase 1
• Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral LipidsCompletedNCT03442972Phase 2/3
• Effect of Galactose Ingestion on Postprandial LipemiaCompletedNCT03439878Not applicable
• Phase I Drug-drug Interaction of Omega-3 and AtorvastatinStatus unknownNCT03438955Phase 1
• Plasma Lipid Response to Glucose DrinkCompletedNCT03435432Not applicable
• Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver DiseaseCompletedNCT03434613Phase 4
• Plasma Lipoprotein Response to Glucagon-like Peptide-2CompletedNCT03422666Phase 2/3
• Effects of MCDG Oil on Postprandial Lipid MetabolismCompletedNCT03415568Not applicable
• Effects of Psyllium on Niacin TolerabilityCompletedNCT03370848Phase 4
• Effect of Alirocumab on Postprandial Hyperlipemia in Patients With Type 2 DiabetesCompletedNCT03344692Phase 3
• Effect of Intake of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol.CompletedNCT03332641Not applicable
• Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk FactorsCompletedNCT03330548Not applicable
• PLATOREL® STUDY IN CARDIOVASCULAR RISΚ ASSESMENTCompletedNCT03329729
• Glybera Registry, Lipoprotein Lipase Deficient (LPLD) PatientsCompletedNCT03293810
• Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol EsterCompletedNCT03284918Not applicable
• Health Outcomes of Patients With Stable Chronic Disease Managed With a Healthcare KioskStatus unknownNCT03274089Not applicable
• Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin ChemoradiationCompletedNCT03225157
• Lipoprotein and Apolipoproteins With Metabolic Liver DiseasesStatus unknownNCT03220971
• Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid StatusCompletedNCT03213288Not applicable
• Effects of Exercise on Fructose-induced Postprandial LipemiaCompletedNCT03173495Not applicable
• Milk as a Recovery Beverage After Exercise for Improving Metabolic HealthCompletedNCT03154216Not applicable
• The Effect of Intranasal Insulin on Hepatic and Intestinal Triglyceride-rich Lipoprotein ProductionCompletedNCT03141827Phase 2/3
• Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and RosuvastatinCompletedNCT03116516Phase 1
• Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication RegistryCompletedNCT03110432
• Clinical Trial to Evaluate the Efficacy and Safety of YHP1701CompletedNCT03103256Phase 3
• Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood TriglycerideCompletedNCT03079648Not applicable
• Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and HyperlipidemiaCompletedNCT03067688Phase 3
• Pharmacokinetic Drug-drug Interaction of CKD-330 and D086CompletedNCT03017950Phase 1
• A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and HyperlipidemiaCompletedNCT03009487Phase 3
• Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male VolunteersCompletedNCT03009474Phase 1
• A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinCompletedNCT02995720Phase 1
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.CompletedNCT02994745Phase 1
• Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With AlirocumabStatus unknownNCT02992301Phase 4
• The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male VolunteersCompletedNCT02982798Phase 1
• A Comparative Study of Rosuvastatin and Atorvastatin in Patients With HyperlipidemiaStatus unknownNCT02979704Phase 2/3
• Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)Status unknownNCT02959762Not applicable
• Dietary Sources of LysophospholipidsTerminatedNCT02952638
• A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and RosuvastatinCompletedNCT02951962Phase 1
• Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia SubjectsWithdrawnNCT02947334Phase 3
• Effect of Lipid Modifying Drugs on HDL Function in Patients With HyperlipidemiaCompletedNCT02942602Not applicable
• Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male VolunteersCompletedNCT02941796Phase 1
• Plasma Triglyceride Lipolysis in Multifactorial ChylomicronemiaCompletedNCT02933138
• Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver DiseaseCompletedNCT02927184Phase 2
• Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia ControlCompletedNCT02913794
• Impact of Reducing Dietary Intake of Red and Processed Meat Intake on Fasting Lipemia in Healthy ParticipantsCompletedNCT02907112Not applicable
• Low Fat Plant-Based Supplemented Diet Effects on Risk Factors for Chronic Non-communicable DiseasesCompletedNCT02905448Not applicable
• Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and DyslipidemiaCompletedNCT02899455Phase 3
• Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and HypertensionCompletedNCT02842359Phase 4
• The Northwest Coalition for Primary Care Practice SupportCompletedNCT02839382Not applicable
• Is There a Relationship Between Hyperlipidemia and Periodontitis?CompletedNCT02826720
• Study to Evaluate the Effects of XXS on Oxidative Stress in Patients With Mild or Moderate HyperlipidemiaCompletedNCT02826083Not applicable
• Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed DyslipidemiaWithdrawnNCT02799758Phase 3
• Effect of Lipoprotein(a) Elimination by Lipoprotein Apheresis on Cardiovascular OutcomesStatus unknownNCT02791802
• Patient-Centred Innovations for Persons With Multimorbidity - QuebecCompletedNCT02789800Not applicable
• DP-R212 Pharmacokinetic StudyStatus unknownNCT02789475Phase 1
• Chart Review of Repatha® in Subjects With HyperlipidaemiaCompletedNCT02770131
• Patient-Centred Innovations for Persons With Multimorbidity - OntarioCompletedNCT02742597Not applicable
• Impact of MayoExpertAdvisor on Provider AdherenceCompletedNCT02742545Not applicable
• Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing SurveillanceCompletedNCT02730390
• Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy SubjectsCompletedNCT02676596Phase 1
• Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia or Mixed DyslipidemiaWithdrawnNCT02670434Phase 3
• A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mgCompletedNCT02659397Phase 2
• A Comparison Study to Evaluate the Pharmacokinetics and Safety of NK-104-CR in Healthy Adult VolunteersCompletedNCT02634034Phase 1

← Hyperlipidemias overview